The government has announced the temporary suspension of the AstraZeneca vaccine in Denmark, Norway, and Iceland because of concerns about blood clots after the vaccine has been administered to some patients with the Chinese communist virus disease (COVID-19).
The company has announced that it is temporarily suspending the use of AstraZeneca vaccine in Denmark, Norway and Iceland.
The company’s main goal is to provide the best possible service to its customers. But the health authorities also cautiously added that the link between the vaccine and the blood clots is still inconclusive.
Austria announced on August 8 that it had suspended the use of a batch of AZ vaccine after a 49-year-old nurse died of “severe clotting problems” days after receiving an anti-vaccine injection in the country.
Another four European countries have also suspended the use of the AZ vaccine, including Estonia, Latvia, Lithuania and Luxembourg. The vaccine has been shipped to 17 European countries, a total of 1 million doses.
The European Medicines Agency (EMA) said that as of March 9, 22 cases of blood clots had been notified among the more than 3 million people vaccinated in the European Economic Area (EEA).
Spanish Health Minister Carolina Darias said today that no cases of AZ vaccine-related thrombosis have been recorded in the country and that the vaccine will continue to be administered.
Darias said that she had been informed that there had been cases of blood clots among people who had recently received the vaccine in Austria, but she also said that “the causal link between the vaccine and the blood clots has not been established so far” and that the European Medicines Agency was assessing the situation.
Recent Comments